T Lymphoblastic Leukemia/Lymphoma — Trials

T Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

140 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 12%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 48.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07784309	A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies	enrolling by invitation	Phase 1	13	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Aug 25, 2026	clinicaltrials
NCT05509855	A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007	enrolling by invitation	—	44	Allotera TherapeuticsINDUSTRY	2	Nov 20, 2024